One Pharmaceutical Manufacturer Did Not Price a New Antiulcer Drug

Multiple Choice

One pharmaceutical manufacturer did not price a new antiulcer drug by adding up the costs of developing and manufacturing the medication and tacking on the amount of profit it wanted to make.Instead,the company justified a higher price than it might otherwise have been able to get from medical insurers by using studies that showed the new drug could help patients avoid expensive surgery and save the insurance companies money.The pharmaceutical company used:

A) value-based pricing
B) noncumulative pricing
C) CRM pricing
D) price bundling
E) market concept pricing